Company intelligence
Acorai
The new standard in heart failure management
About Acorai
Acorai is developing a device for heart failure management through non-invasive cardiac and pulmonary pressure sensing, to help reduce hospitalizations and readmissions. Our product can monitor cardiac and pulmonary pressure sensing non-invasively through a machine-learning analysis of pressure dynamics in acoustics, vibratory, and waveform data. Our technology shows compelling precision, has a low-risk clinical and regulatory pathway, a low dependence on reimbursement, and a fast track to commercialization.
Verified activity
Signals from Acorai
4 published signals
Presence & Recognition
Acorai is attending NLSDays in Stockholm at the poster sessions at 1 pm to hear Filip Peters present the latest and greatest form of heart failure.
Reported by Acorai
Presence & Recognition
Acorai is attending NLSDays in Stockholm this week at the poster sessions at 1 pm to hear Filip Peters present the latest and greatest form the world of heart failure.
Reported by Acorai
Presence & Recognition
Acorai is attending the Nordic Life Science Days poster session tomorrow to learn about its latest developments.
Reported by Filip Peters
Presence & Recognition
Acorai is attending Nordic Life Science Days 2026 in Stockholm on 8-9 September.
Reported by Acorai